- Home
- ROIV vs X Comparison
ROIV vs X Comparison
Compare ROIV & X Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- X
- Stock Information
- Founded
- ROIV 2014
- X 1901
- Country
- ROIV United Kingdom
- X United States
- Employees
- ROIV N/A
- X N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- X Steel/Iron Ore
- Sector
- ROIV Health Care
- X Industrials
- Exchange
- ROIV Nasdaq
- X Nasdaq
- Market Cap
- ROIV 8.4B
- X 8.7B
- IPO Year
- ROIV N/A
- X N/A
- Fundamental
- Price
- ROIV $11.27
- X $36.58
- Analyst Decision
- ROIV Strong Buy
- X Strong Buy
- Analyst Count
- ROIV 8
- X 6
- Target Price
- ROIV $17.93
- X $41.51
- AVG Volume (30 Days)
- ROIV 5.1M
- X 9.3M
- Earning Date
- ROIV 02-11-2025
- X 01-30-2025
- Dividend Yield
- ROIV N/A
- X 0.54%
- EPS Growth
- ROIV N/A
- X N/A
- EPS
- ROIV 5.89
- X 1.57
- Revenue
- ROIV $129,128,999.00
- X $16,275,000,000.00
- Revenue This Year
- ROIV $15.98
- X N/A
- Revenue Next Year
- ROIV N/A
- X $6.22
- P/E Ratio
- ROIV $1.91
- X $23.23
- Revenue Growth
- ROIV 145.68
- X N/A
- 52 Week Low
- ROIV $9.69
- X $26.92
- 52 Week High
- ROIV $13.06
- X $48.85
- Technical
- Relative Strength Index (RSI)
- ROIV 46.46
- X 57.70
- Support Level
- ROIV $10.89
- X $35.74
- Resistance Level
- ROIV $11.26
- X $37.42
- Average True Range (ATR)
- ROIV 0.36
- X 1.68
- MACD
- ROIV -0.02
- X 0.65
- Stochastic Oscillator
- ROIV 47.75
- X 85.15
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About X United States Steel Corporation
United States Steel Corp operates primarily in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It primarily serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.